Established
Semaglutide
GLP-1 receptor agonist. Ozempic, Wegovy, Rybelsus
Fármacos incretínicos
Evidencia dos ensaios por fármaco, cos datos de descontinuación que a comercialización tende a omitir.
Established
Tirzepatide
Dual GIP / GLP-1 receptor agonist. Mounjaro, Zepbound
Established
Liraglutide
GLP-1 receptor agonist. Victoza, Saxenda
Established
Dulaglutide
GLP-1 receptor agonist. Trulicity
Promising
Oral semaglutide
GLP-1 receptor agonist, oral. Rybelsus
Popular but weak
Compounded GLP-1 preparations
Unapproved compounded preparation. Various, unbranded
Lectura relacionada
Fasting Evidence
Intermittent fasting, time-restricted eating and meal timing, judged on the trial data.
Metabolism Review
Energy expenditure, insulin resistance and metabolic adaptation, without the folklore.
Weight Loss Evidence
Diets, drugs, behaviour and maintenance — ranked by the strength of the evidence behind them.
Sleep Evidence
Sleep, circadian rhythm and the wearables that claim to measure both.
Esta páxina foi traducida automáticamente do inglés. As citas e os números non mudaron. Le o orixinal en inglés se algo soa raro. Ler o orixinal en inglés